Polaryx Therapeutics, Inc.
PLYX
Last
$2.00
Day
+0.0%
1y
-94.3%
5y
-94.3%
52w
-95.9%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1233d
EMA 21
2.07
EMA 50
2.19
EMA 200
8.62
20d high
-9.3%
5y high
-95.9%
5y range
0th
Positions held
Your positionsPLYX isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-18
Hold
avoid
Signal
Strong Sell
Target
$2.21
Stop
$1.83
Stop distance
8.5%
Target vs last
+10.5%
Fundamentals
| Market cap | $99.69M | Enterprise value | $88.15M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 9.13 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -96.6% | ROA | -42.5% | Debt / equity | — |
| Current ratio | 13.53 | Free cash flow | -$2.09M | Analyst recommendation | none | Mean target | $7.50 |
| 52w high | $48.91 | 52w low | $1.85 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$1.4M | -$2.5M | -$1.5M | -$1.4M | -$1.0M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$1.4M | -$2.0M | -$0.9M | -$1.0M | -$0.9M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — |
| Net income | -$9.0M | -$30.4M | -$3.8M |
| Gross margin | — | — | — |
| Gross profit | — | — | — |
| Operating income | -$7.8M | -$4.4M | -$3.8M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsPLYX · daily-7.0% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin